U.S. Biliary Stents Market Size Sets New Record, Projected at USD 474 Million by 2025 | CAGR of 5.2%

June 18, 2025 02:48 AM AEST | By EIN Presswire
 U.S. Biliary Stents Market Size Sets New Record, Projected at USD 474 Million by 2025 | CAGR of 5.2%
Image source: EIN Presswire

The increase in availability of an array of different types of biliary stents is anticipated to boost the U.S. biliary rents market during the forecast period. PORTLAND, OR, UNITED STATES, June 17, 2025 /EINPresswire.com/ -- U.S. Biliary Stents Market Size is poised to Reach USD 474 Million by 2025 witnessing a Growing CAGR of 5.2% During the Forecast Period. The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends. The market study is a helpful source of information for the frontrunners, new entrants, investors, and shareholders in crafting strategies for the future and heightening their position in the market.

𝐖𝐡𝐚𝐭 𝐚𝐫𝐞 𝐭𝐡𝐞 𝐃𝐫𝐢𝐯𝐢𝐧𝐠 𝐅𝐚𝐜𝐭𝐨𝐫𝐬 𝐎𝐟 𝐁𝐢𝐥𝐢𝐚𝐫𝐲 𝐒𝐭𝐞𝐧𝐭𝐬 𝐌𝐚𝐫𝐤𝐞𝐭?

𝐇𝐢𝐠𝐡 𝐩𝐫𝐞𝐯𝐚𝐥𝐞𝐧𝐜𝐞 𝐨𝐟 𝐛𝐢𝐥𝐢𝐚𝐫𝐲 𝐝𝐢𝐬𝐞𝐚𝐬𝐞𝐬, 𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐢𝐜𝐚𝐥 𝐚𝐝𝐯𝐚𝐧𝐜𝐞𝐦𝐞𝐧𝐭𝐬 𝐚𝐬𝐬𝐨𝐜𝐢𝐚𝐭𝐞𝐝 𝐰𝐢𝐭𝐡 𝐛𝐢𝐥𝐢𝐚𝐫𝐲 𝐬𝐭𝐞𝐧𝐭𝐬 𝐚𝐧𝐝 𝐬𝐮𝐫𝐠𝐞 𝐢𝐧 𝐝𝐞𝐦𝐚𝐧𝐝 𝐟𝐨𝐫 𝐦𝐢𝐧𝐢𝐦𝐚𝐥𝐥𝐲 𝐢𝐧𝐯𝐚𝐬𝐢𝐯𝐞 𝐩𝐫𝐨𝐜𝐞𝐝𝐮𝐫𝐞𝐬 𝐡𝐚𝐯𝐞 𝐬𝐩𝐮𝐫𝐫𝐞𝐝 𝐭𝐡𝐞 𝐠𝐫𝐨𝐰𝐭𝐡. 𝐎𝐧 𝐭𝐡𝐞 𝐨𝐭𝐡𝐞𝐫 𝐡𝐚𝐧𝐝, 𝐬𝐞𝐯𝐞𝐫𝐚𝐥 𝐜𝐨𝐦𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬 𝐚𝐧𝐝 𝐡𝐢𝐠𝐡 𝐜𝐨𝐬𝐭𝐬 𝐚𝐬𝐬𝐨𝐜𝐢𝐚𝐭𝐞𝐝 𝐰𝐢𝐭𝐡 𝐛𝐢𝐥𝐢𝐚𝐫𝐲 𝐬𝐭𝐞𝐧𝐭𝐬 𝐡𝐚𝐯𝐞 𝐫𝐞𝐬𝐭𝐫𝐚𝐢𝐧𝐞𝐝 𝐭𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭. 𝐇𝐨𝐰𝐞𝐯𝐞𝐫, 𝐝𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐨𝐟 𝐢𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐯𝐞 𝐬𝐦𝐚𝐫𝐭𝐩𝐡𝐨𝐧𝐞 𝐚𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬 𝐡𝐚𝐯𝐞 𝐩𝐚𝐯𝐞𝐝 𝐭𝐡𝐞 𝐰𝐚𝐲 𝐟𝐨𝐫 𝐦𝐮𝐥𝐭𝐢𝐩𝐥𝐞 𝐨𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐬𝐞𝐠𝐦𝐞𝐧𝐭.

𝐊𝐞𝐲 𝐁𝐞𝐧𝐞𝐟𝐢𝐭𝐬 𝐟𝐨𝐫 𝐔.𝐒. 𝐛𝐢𝐥𝐢𝐚𝐫𝐲 𝐬𝐭𝐞𝐧𝐭𝐬 𝐦𝐚𝐫𝐤𝐞𝐭:

• The report provides an extensive analysis of the current market trends and future estimations of the U.S. biliary stents market.
• The U.S. biliary stents market top player positioning is comprehensively analyzed in the report.
• The U.S. biliary stents market share is comprehensively analyzed with respect to the application, type, and end user.
• U.S. biliary market growth analysis by type helps understand the significance of the different types of biliary stents available in the market.
• Key manufacturers involved in the U.S. biliary stents market are listed and analyzed in this report to understand the competitive scenario of the market.

𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐑𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐆𝐫𝐚𝐩𝐡𝐬 𝐚𝐧𝐝 𝐅𝐢𝐠𝐮𝐫𝐞𝐬 𝐇𝐞𝐫𝐞:
https://www.alliedmarketresearch.com/request-sample/5211

𝐓𝐨𝐩 𝐔.𝐒. 𝐁𝐢𝐥𝐢𝐚𝐫𝐲 𝐒𝐭𝐞𝐧𝐭𝐬 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬:-

• Boston Scientific Corporation
• Cook Medical
• Abbott Laboratories Executive
• CONMED Corporation
• Becton, Dickinson and Company
• Olympus Corporation
• B. Braun Melsungen AG
• Medtronic
• Terumo Medical Corporation
• Merit Medical Systems, Inc.

𝐔.𝐒. 𝐁𝐢𝐥𝐢𝐚𝐫𝐲 𝐒𝐭𝐞𝐧𝐭𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧:-

By Type, The wide application of specialized metal stents such as self-expandable metal stents (SEMs) in the treatment of biliary comorbidities has fueled the growth of the market. The plastic biliary stents segment is expected to grow at the highest CAGR of 5.8% till 2025. This is due to the cost-effectiveness associated with the product.

By Application, The fact that biliary leaks are one of the most common modalities that are treated using stents has made the segment come out as the largest revenue contributor to the market.

Based on End-User, The availability of trained medical staff in hospitals helps provide better services to the patient which, in turn, has contributed toward the growth of the market. Ambulatory surgical centers has garnered the highest CAGR and this is due to increase in the number of ASCs in the U.S. along with the fact that they provide cost-effective services as well as a convenient environment for surgery.

𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.alliedmarketresearch.com/connect-to-analyst/5211

Our Market Research Solution Provides You Answer to Below Mentioned Question:

• Which are the driving factors responsible for the growth of market?
• Which are the roadblock factors of this market?
• What are the new opportunities, by which market will grow in coming years?
• What are the trends of this market?
• Which are main factors responsible for new product launch?
• How big is the global & regional market in terms of revenue, sales and production?
• How far will the market grow in forecast period in terms of revenue, sales and production?
• Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
• How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
• Which region has more opportunities?

By Region Outlook

• North America
(U.S., Canada, Mexico)
• Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
• Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
• LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)

Contact Details:

David Correa
USA/Canada (Toll-Free): +1-800-792-5285, +1-503-894-6022
[email protected]

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

David Correa
Allied Market Research
+ 1800-792-5285
email us here
Visit us on social media:
LinkedIn
Facebook
YouTube
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.